Tyler Van Buren

Stock Analyst at TD Cowen

(2.47)
# 2,285
Out of 5,154 analysts
62
Total ratings
46%
Success rate
1.94%
Average return

Stocks Rated by Tyler Van Buren

Soleno Therapeutics
Feb 26, 2026
Maintains: Buy
Price Target: $120$85
Current: $39.68
Upside: +114.21%
Arcutis Biotherapeutics
Feb 26, 2026
Maintains: Buy
Price Target: $30$35
Current: $24.00
Upside: +45.83%
CRISPR Therapeutics AG
Feb 13, 2026
Maintains: Hold
Price Target: $40$45
Current: $56.50
Upside: -20.35%
C4 Therapeutics
Dec 2, 2025
Initiates: Buy
Price Target: n/a
Current: $3.04
Upside: -
Biohaven
Nov 5, 2025
Maintains: Buy
Price Target: $50$15
Current: $9.92
Upside: +51.21%
MBX Biosciences
Nov 4, 2025
Initiates: Buy
Price Target: n/a
Current: $30.55
Upside: -
Travere Therapeutics
Oct 31, 2025
Maintains: Buy
Price Target: $30$40
Current: $27.24
Upside: +46.84%
BridgeBio Pharma
Oct 30, 2025
Maintains: Buy
Price Target: $60$95
Current: $65.36
Upside: +45.35%
Gilead Sciences
Oct 23, 2025
Maintains: Buy
Price Target: $115$125
Current: $143.93
Upside: -13.15%
IDEAYA Biosciences
Jul 22, 2025
Initiates: Buy
Price Target: n/a
Current: $33.19
Upside: -
Initiates: Buy
Price Target: n/a
Current: $61.88
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $11.30
Upside: -
Initiates: Buy
Price Target: n/a
Current: $18.47
Upside: -
Initiates: Buy
Price Target: n/a
Current: $32.97
Upside: -
Maintains: Hold
Price Target: $70$60
Current: $52.52
Upside: +14.24%
Initiates: Buy
Price Target: n/a
Current: $5.74
Upside: -
Initiates: Buy
Price Target: n/a
Current: $6.85
Upside: -
Maintains: Buy
Price Target: $1,030$1,200
Current: $759.86
Upside: +57.92%
Initiates: Buy
Price Target: n/a
Current: $35.87
Upside: -
Initiates: Buy
Price Target: n/a
Current: $29.86
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $40.15
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $114.33
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $73.05
Upside: -
Downgrades: Market Perform
Price Target: n/a
Current: $1.33
Upside: -
Initiates: Outperform
Price Target: $70
Current: $32.97
Upside: +112.31%
Initiates: Outperform
Price Target: n/a
Current: $2.30
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $13.60
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $35.04
Upside: -
Initiates: Overweight
Price Target: $225
Current: $12.07
Upside: +1,764.13%
Initiates: Overweight
Price Target: $875
Current: $6.98
Upside: +12,435.82%
Initiates: Overweight
Price Target: $40
Current: $15.10
Upside: +164.90%
Maintains: Overweight
Price Target: $35$30
Current: $13.57
Upside: +121.08%
Initiates: Overweight
Price Target: $50
Current: $1.33
Upside: +3,659.40%
Initiates: Overweight
Price Target: $30
Current: $0.50
Upside: +5,891.61%
Downgrades: Market Perform
Price Target: n/a
Current: $11.54
Upside: -
Downgrades: Market Perform
Price Target: n/a
Current: $31.05
Upside: -